
Shilpa Medicare and Orion Partner to Expand Access to a Nivolumab Biosimilar in Europe
New immuno-oncology deal marks the second major announcement as Shilpa and Orion deepen strategic

New immuno-oncology deal marks the second major announcement as Shilpa and Orion deepen strategic

Third major international mandate in recent months reinforces accelerating biotech traction and long-term revenue